Close

Lannett (LCI) Receives FDA Extension on Methylphenidate Hydrochloride ER Tabs Document Submission

November 30, 2016 6:56 AM EST Send to a Friend
Lannett Company, Inc. (NYSE: LCI) announced that the U.S. Food and Drug Administration (FDA) granted the company a 90-day extension ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login